Savanna Biotherapeutics

Neurona Therapeutics

This company develops off-the-shelf regenerative neural cell therapies for patients with drug-resistant epilepsy and other chronic disorders of the central nervous system.

BE Therapeutics

This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.

Neuroplast

This company develops autologous stem cell therapies to treat patients with neurodegenerative diseases including spinal cord injuries and amyotrophic lateral sclerosis.

MindImmune Therapeutics

This company develops monoclonal antibody therapeutics to treat neurodegenerative diseases and neuroinflammation for patients with central nervous system disorders.

Cellergy Therapeutics

This biotechnology company develops purified mitochondrial transplantation therapies to treat patients with neurodegenerative diseases, muscle degeneration and age-related conditions.

Neumirna Therapeutics

This biotechnology company develops microRNA-based therapies to treat patients with neurological disorders, including drug-resistant epilepsy and Parkinson's disease.

Vigil Neuroscience

Vigil Neuroscience develops microglia-targeted medicines to treat neurodegenerative diseases for patients with rare and common brain disorders.

Scripta Therapeutics

The company develops therapeutics that modulate transcription factor activity to treat neurodegenerative diseases for patients with conditions such as Alzheimer's and Parkinson's.